Global Biofeedback Measurement Instrument Market to Rise During the COVID-19 Crisis Period Owing to Increasing Consumer Awareness
Increasing cases of neurological disorders, including depression, anxiety, ADHD, and other dementias, are expected to fuel the market growth of the biofeedback instrument market during the forecast period. For example, according to the World Alzheimer's Study released by Alzheimer's Disease International (ADI), new cases of dementia across regions in 2015 were 4.9 million (49.0 percent) in Asia Pacific, 2.5 million (25.0 percent) in Europe, 1.7 million (18.0 percent) in the Americas and 0.8 million (8.0 per cent) in Africa. In addition, according to Parkinson's UK, about 137,000 people in the UK suffered from Parkinson's disease in 2015.
Parkinson's disease is the second most common age-related neurodegenerative condition after Alzheimer's. For example, according to Parkinson's UK, the estimated number of people with Parkinson's disease in Northern Ireland in 2015 was 241, 157 of whom were male and 85 were female.
The global biofeedback instrument market size was estimated at US$ 148.68 million in 2019 and is projected to have a CAGR of 6.2 percent over the forecast years (2020-2027).
Global Biofeedback Measurement Instrument Market- Regional Insights
North America is anticipated to maintain a leading role in the industry due to a large number of cases of neurological disorders. According to the Global Burden of Disease report, 9.3 percent of males and 11.9 per cent of females were affected by mental health problems in 2017. The study also found that 2.7% of males and 4.1% of females had depression.
To know the latest trends and insights prevalent in the global Biofeedback Measurement Instrument Market, click here: https://www.globenewswire.com/news-release/2020/04/27/2022554/0/en/At-a-CAGR-of-6-2-Global-Biofeedback-Measurement-Instrument-Market-to-Surpass-US-240-6-Mn-by-end-of-2027-Says-CMI.html
Comments
Post a Comment